Discover how SciY empowers scientists

FHS
May 31, 2024
2:47 pm

In this interview, NewsMedical talks to Santi Dominguez about the genesis of SCiY, and how the
consortium intends to empower scientists and researchers.

When it comes to ketamine, Meta’s posting policy is no party to decipher

People keep talking about ketamine. The drug has become a favorite of celebrities, billionaires, and ordinary patients, many of whom view it as a potential

March 7, 2024

New study reveals long-term brainstem damage in COVID-19 survivors using advanced MRI scans

A study using 7T QSM identifies microstructural changes in the brainstem of COVID-19 survivors, suggesting links to long-term neuroinflammatory responses.

October 10, 2024

Mesoblast wins long-awaited approval for cell therapy

Mesoblast’s stock surged on Thursday after the company won FDA approval for its twice-rejected graft-versus-host disease therapy. Remestemcel-L is the first mesenchymal stromal cell therapy

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.